Fermish

Noida, India Founded: 2005 • Age: 21 yrs
Offers regulatory submissions, medical writing, and compliance for pharma manufacturers.

About Fermish

Fermish is a Healthcare company based in Noida (India) founded in 2005. It offers regulatory submissions, medical writing, and compliance for pharma manufacturers. It operates on a B2B and Consulting Services model in Healthcare and Consumer sectors. Its Indian entity Fermish Clinical Technologies Private Limited reported revenue of β‚Ή4.66 Cr. Fermish offers products and services including Regulatory Submissions, Medical Writing, and Regulatory Auditing. Its focus areas include Life Sciences, Medical Devices, Product Development and Clinical Trials.

Company details

Fermish, based in Noida, India, specializes in regulatory services for pharmaceuticals, active ingredients, and medical devices. They assist manufacturers with submissions, writing, and compliance for national and international markets, drawing on over 30 years of experience. Services include product development support, clinical trials, and post-marketing surveillance to ensure quality and timely approvals. They cater to diverse clients in the life sciences sector through proactive problem-solving and expert networks.

Key Metrics
  • Annual Revenue
    ₹4.66 Cr

    FY 2025 · -7% YoY

  • Net Profit
    ₹31 Lakh

    FY 2025 · 7% margin

  • EBITDA
    ₹57.3 Lakh

    FY 2025 · 12% margin

Products & Services of Fermish

Fermish offers a comprehensive portfolio of products and services, including Regulatory Submissions, Medical Writing, and Regulatory Auditing.

Regulatory Submissions
Regulatory Services

Handles submissions for drugs, devices, and food to ensure compliance.

Medical Writing
Writing Services

Provides clinical and dossier writing for pharmaceutical documentation.

Regulatory Auditing
Compliance Services

Offers audits and support for pre and post approval processes.

Board of directors of Fermish Clinical Technologies Private Limited (Fermish)

Fermish Clinical Technologies Private Limited is the primary company behind Fermish. The board of Fermish Clinical Technologies Private Limited currently have 2 directors; the longest-serving is Mumtaz Khan, appointed in 2005.

DirectorDesignationAppointedTenureEntity
Mumtaz Khan
DIN 01093263
Director19 Jan 200521 yrs 9 moFermish Clinical Technologies Private Limited
Khalid Khan
DIN 00791459
Director19 Jan 200521 yrs 9 moFermish Clinical Technologies Private Limited

Financials of Fermish

Figures of Fermish Clinical Technologies Private Limited, the primary company behind Fermish, for FY 2025. Revenue was ₹4.66 Cr (-7% year on year). Net profit was ₹31 Lakh (7% margin). EBITDA was ₹57.3 Lakh (12% margin). Revenue has grown at a compounded annual rate of +1% over three years and +10% over five years.

  • ₹4.66 CrRevenue · FY 2025 · -7% YoY
  • ₹31 LakhNet profit · 7% margin
  • ₹57.3 LakhEBITDA · 12% margin
  • ₹1 LakhPaid-up capital
  • +1%Revenue CAGR, 3 years
  • +10%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Fermish Clinical Technologies Private Limited are on its company page.

Premium access

Detailed financial statements for Fermish

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Web traffic of Fermish

Websites that share an audience with Fermish (fermish.com).

Similar websites

Websites whose visitors overlap most with Fermish. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
gvkbio.com
26%
View details

Top companies in Clinical Trials & Research Tech

2 companies that operate in the same segment as Fermish (Clinical Trials & Research Tech) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare.
2004Ahmedabad, Gujarat, IndiaUSD 50.52 M902
Generic injectables for oncology and anesthesiology are manufactured.
1989Hyderabad, Telangana, IndiaUSD 4.22 M228
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Fermish

Fermish was founded in 2005.

Fermish is headquartered in Noida, India. It is registered at Noida, Uttar Pradesh, India.

The primary company behind Fermish, Fermish Clinical Technologies Private Limited, reported revenue of β‚Ή4.66 Cr for FY 2025, down 7% year on year.

Fermish, based in Noida, India, specializes in regulatory services for pharmaceuticals, active ingredients, and medical devices. They assist manufacturers with submissions, writing, and compliance for national and international markets, drawing on over 30 years of experience. Services include product development support, clinical trials, and post-marketing surveillance to ensure quality and timely approvals. They cater to diverse clients in the life sciences sector through proactive problem-solving and expert networks.

Fermish offers Regulatory Submissions, Medical Writing, and Regulatory Auditing.

Fermish operates through Fermish Clinical Technologies Private Limited.

The legal entities of Fermish currently have 2 directors, including Mumtaz Khan, Khalid Khan.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available